Loading institutional data...
Loading institutional data...
Held by 1,009 of 5,944 reporting institutions (99th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $247.45 today, the market must believe free cash flow compounds 13.8%/yr for a decade (off $1.0B normalized FCF).
The market's 13.8% is more optimistic than its 9-yr track record.
2-stage DCF · 0.11B shares · net debt $5.3B
mean 11.1% · volatility σ 38% · implied rate exceeded in 3/9 yrs
Central path = implied 13.8%/yr growth; shaded band = ±1σ (38%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 26% of free cash flow, leaving room to grow it and fund buybacks. Last year: $353M dividends + $450M buybacks = $803M returned on $1.4B FCF.
9 consecutive years of dividend increases · 8%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Modest payoff on reinvested capital. Current ROIC on all capital: 8%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $420M covers the $413M due within a year 1.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2026-06-30 (10-Q).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~3.5% on $4.7B of debt. Interest last disclosed in FY2023 (no longer broken out).
Cash of $420M is below short-term debt of $504M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 14-yr range · 100th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.3× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 65.4 | 65.2 | 61.5 | 61.0 | 65.3 | 67.0 | 67.1 | 66.8 |
| Gross Profit | 34.6 | 34.8 | 38.5 | — | — | — | — | — |
| SG&A | 18.9 | 18.9 | 16.4 | 16.0 | 19.0 | 17.7 | 17.9 | 17.8 |
| Operating Income | 14.6 | 15.9 | 20.9 | 22.1 | 14.4 | 13.6 | 13.6 | 14.1 |
| Income Tax | 2.4 | 3.2 | 4.9 | 5.5 | 2.7 | 2.7 | 2.8 | 2.8 |
| Net Income | 9.8 | 11.1 | 15.2 | 18.5 | 9.6 | 9.2 | 8.8 | 9.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on DGX: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.04B 100.0% | $9.87B 100.0% | $9.25B 100.0% | $9.88B 100.0% | $10.79B 100.0% | $9.44B 100.0% | $7.73B 100.0% | $7.53B 100.0% | $7.40B 100.0% | $7.21B 100.0% |
| Cost of Revenue | $7.37B 66.8% | $6.63B 67.1% | $6.20B 67.0% | $6.45B 65.3% | $6.58B 61.0% | $5.80B 61.5% | $5.04B 65.2% | $4.93B 65.4% | $4.72B 63.8% | $4.62B 64.0% |
| Gross Profit | — | — | — | — | — | $3.63B 38.5% | $2.69B 34.8% | $2.60B 34.6% | $2.68B 36.2% | $2.90B 40.2% |
| Selling, General & Admin | $1.97B 17.8% | $1.77B 17.9% | $1.64B 17.7% | $1.87B 19.0% | $1.73B 16.0% | $1.55B 16.4% | $1.46B 18.9% | $1.42B 18.9% | $1.44B 19.5% | $1.38B 19.1% |
| Total Operating Expenses | $9.48B 85.9% | $8.53B 86.4% | $7.99B 86.4% | $8.46B 85.6% | $8.41B 77.9% | $7.47B 79.1% | $6.50B 84.1% | $6.43B 85.4% | $6.24B 84.3% | $5.94B 82.3% |
| Operating Income | $1.56B 14.1% | $1.35B 13.6% | $1.26B 13.6% | $1.43B 14.4% | $2.38B 22.1% | $1.97B 20.9% | $1.23B 15.9% | $1.10B 14.6% | $1.17B 15.7% | $1.28B 17.7% |
| Interest Expense | — | — | $163.0M 1.8% | $148.0M 1.5% | $152.0M 1.4% | $166.0M 1.8% | $180.0M 2.3% | $169.0M 2.2% | $153.0M 2.1% | $144.0M 2.0% |
| Other Income (Expense), net | -$238.0M -2.2% | -$171.0M -1.7% | -$132.0M -1.4% | -$193.0M -2.0% | $218.0M 2.0% | -$87.0M -0.9% | -$155.0M -2.0% | -$175.0M -2.3% | -$135.0M -1.8% | -$191.0M -2.6% |
| Pretax Income | $1.32B 11.9% | $1.18B 11.9% | $1.13B 12.2% | $1.24B 12.5% | $2.60B 24.1% | $1.88B 20.0% | $1.08B 13.9% | $926.0M 12.3% | $1.03B 13.9% | $1.09B 15.1% |
| Income Tax Expense | $314.0M 2.8% | $273.0M 2.8% | $248.0M 2.7% | $264.0M 2.7% | $597.0M 5.5% | $460.0M 4.9% | $247.0M 3.2% | $182.0M 2.4% | $241.0M 3.3% | $429.0M 5.9% |
| Net Income | $992.0M 9.0% | $871.0M 8.8% | $854.0M 9.2% | $946.0M 9.6% | $2.00B 18.5% | $1.43B 15.2% | $858.0M 11.1% | $736.0M 9.8% | $772.0M 10.4% | $645.0M 8.9% |
| Per Share | ||||||||||
| EPS (Basic) | $8.87 | $7.78 | $7.59 | $8.10 | $15.85 | $10.62 | $6.36 | $5.39 | $5.63 | $4.58 |
| EPS (Diluted) | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 | $10.47 | $6.28 | $5.29 | $5.50 | $4.51 |
| Weighted Avg Shares (Basic) | 111.0M | 111.0M | 112.0M | 116.0M | 125.0M | 134.0M | 134.0M | 136.0M | 137.0M | 140.0M |
| Weighted Avg Shares (Diluted) | 113.0M | 113.0M | 113.0M | 118.0M | 128.0M | 136.0M | 136.0M | 139.0M | 140.0M | 142.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| DGX | $27.5B | 28.3× | 15.4× | 2.5× | 11.8% | 33.2% | 9.0% | 13.8% | 7.7% | 2.7× | 1,009 |
Peers = companies sharing DGX's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.